These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Giambalvo CT. Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868 [Abstract] [Full Text] [Related]
17. Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs. Knepper SM, Grunewald GL, Rutledge CO. J Pharmacol Exp Ther; 1988 Nov; 247(2):487-94. PubMed ID: 3263494 [Abstract] [Full Text] [Related]
18. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [Abstract] [Full Text] [Related]
19. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. Parker EM, Cubeddu LX. J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738 [Abstract] [Full Text] [Related]
20. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Crespi D, Mennini T, Gobbi M. Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]